RT is characterized by profound alterations in immune checkpoint molecules, including Programmed Death-1 (PD-1), Lymphocyte Activation Gene-3 (LAG3), and T-cell Immunoreceptor with Ig and ITIM domains (TIGIT), which collectively impair anti-tumor immunity [87]. The gene discussed is LAG3; the disease is neoplasm.